NEW YORK /PRNewswire/ — Columbia Care LLC (“CC”), a leading national medical marijuana product development, manufacturing and distribution company, has announced the launch of its line of controlled-dose, solid-fill medical cannabinoid capsules. These capsules are the first and only pharmaceutical quality, controlled-dose, solid-fill pills available to patients, not only in the United States, but in any…
Debiopharm International SA Announces Clinical Collaboration in Cancer Immunotherapy
LAUSANNE, Switzerland /PRNewswire/ — Debiopharm International has announced that it has entered into a collaboration agreement with Merck KGaA, Darmstadt, Germany, and Pfizer to evaluate Debio 1143, an oral, small molecule inhibitor of IAPs (Inhibitor of Apoptosis Proteins), in combination with avelumab, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody, in patients with advanced or metastatic Non-Small Cell…
Studies Aim To Develop Cannabis Strains That Specifically Target Cancer Pain And Nausea
CORAL SPRINGS, Florida /PRNewswire/ — Medical Cannabis’ biggest strength continues to be science as research and development drives sector forward with more consumers opting for marijuana over traditional treatment methods. Investors continue to pour millions of dollars into the newest studies and development of Medical Marijuana Applications as more states push towards legalization. Veritas Pharma…
Defymed Receives Support From JDRF To Fight Type 1 Diabetes
Defymed, a French biotechnology company specializing in the development of bioartificial organs today announced a partnership with JDRF, the leading global organization funding type 1 diabetes (T1D) research. This new investment gives Defymed the opportunity to advance its pre-clinical studies in order to demonstrate the MAILPAN immunoprotection properties, safety and function. This is an essential step…